Abstract:We have previously reported the presence and the persistence of immunoreactive GnRH cells in the rat anterior pituitary in the absence of exogenous GnRH. To substantiate the hypothesis of its endogenous production, we have investigated the presence of GnRH mRNA in rat anterior pituitary tissue using a reverse transcription-polymerase chain reaction (RT-PCR) amplification protocol. Total RNA from rat anterior pituitary, hypothalamus (positive control), and muscle (negative control) was reverse transcribed to th… Show more
“…In this study, both GnRH and GnRH-R mRNAs were detected in nontumorous pituitaries. Detection of GnRH-containing cells (12) and of GnRH mRNA in the rat anterior pituitary has been reported (13) and suggests that endogenously synthesized GnRH may be involved in local regulatory mechanisms.…”
Section: Discussionmentioning
confidence: 97%
“…The presence of GnRH-producing cells (11) and of GnRH messenger RNA (mRNA) (12) has been reported in rat anterior pituitary, which suggests that endogenously synthesized GnRH may be involved in local regulatory mechanisms. Alexander et al (13) detected GnRH-R mRNA in human pituitary adenomas in vitro.…”
In the nontumorous pituitary, GnRH stimulates the release and synthesis of LH and FSH by gonadotroph cells via the GnRH receptor (GnRH-R). Little is known, however, about expression of GnRH and GnRH-R messenger RNAs (mRNAs) in nontumorous pituitary tissue and in adenomas. To learn more about the distribution and regulatory roles of GnRH and its receptor, we investigated the expression of both GnRH and GnRH-R mRNAs in nontumorous human pituitary and in various types of pituitary adenomas using the RT-PCR, in situ hybridization, and in situ hybridization in combination with RT-PCR (in situ RT-PCR). Using RT-PCR, GnRH mRNA was found to be expressed in normal human pituitaries and in all types of adenomas. Similarly, GnRH-R mRNA was expressed in nontumorous human pituitaries and in most, but not all, adenomas. These included 5 gonadotroph adenomas, 6 null cell adenomas, 1 of 2 GH-producing tumors, and 1 of 2 ACTH-producing adenomas, but not in the 2 PRL-producing adenomas examined. In situ hybridization studies showed GnRH and GnRH-R mRNAs in all 3 nontumorous pituitaries and in 12 of 33 (36.4%) and 10 of 33 adenomas (30.3%), respectively. Using an indirect in situ RT-PCR technique to increase the sensitivity of the in situ localization, GnRH and GnRH-R mRNAs were detected in 29 (87.9%) and 25 (75.8%) of 33 adenomas, respectively. This is the first report of the localization of GnRH and GnRH-R mRNAs in individual pituitary adenoma cells using in situ RT-PCR. The frequent expression of GnRH and GnRH-R mRNAs in pituitary cells suggests that GnRH has autocrine/paracrine functions in nontumorous and neoplastic pituitary tissues. (J Clin Endocrinol Metab
“…In this study, both GnRH and GnRH-R mRNAs were detected in nontumorous pituitaries. Detection of GnRH-containing cells (12) and of GnRH mRNA in the rat anterior pituitary has been reported (13) and suggests that endogenously synthesized GnRH may be involved in local regulatory mechanisms.…”
Section: Discussionmentioning
confidence: 97%
“…The presence of GnRH-producing cells (11) and of GnRH messenger RNA (mRNA) (12) has been reported in rat anterior pituitary, which suggests that endogenously synthesized GnRH may be involved in local regulatory mechanisms. Alexander et al (13) detected GnRH-R mRNA in human pituitary adenomas in vitro.…”
In the nontumorous pituitary, GnRH stimulates the release and synthesis of LH and FSH by gonadotroph cells via the GnRH receptor (GnRH-R). Little is known, however, about expression of GnRH and GnRH-R messenger RNAs (mRNAs) in nontumorous pituitary tissue and in adenomas. To learn more about the distribution and regulatory roles of GnRH and its receptor, we investigated the expression of both GnRH and GnRH-R mRNAs in nontumorous human pituitary and in various types of pituitary adenomas using the RT-PCR, in situ hybridization, and in situ hybridization in combination with RT-PCR (in situ RT-PCR). Using RT-PCR, GnRH mRNA was found to be expressed in normal human pituitaries and in all types of adenomas. Similarly, GnRH-R mRNA was expressed in nontumorous human pituitaries and in most, but not all, adenomas. These included 5 gonadotroph adenomas, 6 null cell adenomas, 1 of 2 GH-producing tumors, and 1 of 2 ACTH-producing adenomas, but not in the 2 PRL-producing adenomas examined. In situ hybridization studies showed GnRH and GnRH-R mRNAs in all 3 nontumorous pituitaries and in 12 of 33 (36.4%) and 10 of 33 adenomas (30.3%), respectively. Using an indirect in situ RT-PCR technique to increase the sensitivity of the in situ localization, GnRH and GnRH-R mRNAs were detected in 29 (87.9%) and 25 (75.8%) of 33 adenomas, respectively. This is the first report of the localization of GnRH and GnRH-R mRNAs in individual pituitary adenoma cells using in situ RT-PCR. The frequent expression of GnRH and GnRH-R mRNAs in pituitary cells suggests that GnRH has autocrine/paracrine functions in nontumorous and neoplastic pituitary tissues. (J Clin Endocrinol Metab
“…The anterior pituitary has been found to harbor, apart from classical adenohypophyseal hormones, several other peptides which participate in cell-tocell interactions and modulate hormonal secretion (2). In this context, the synthesis of hypothalamic releasing factors, such as thyrotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and gonadotropin-releasing hormone has been demonstrated recently in normal and tumoral anterior pituitaries (5,7,9,10,12). These factors exert direct effects on anterior pituitary hormone production and release as well as on cell differentiation and growth, via their receptors located on the pituicytes.…”
Section: Discussionmentioning
confidence: 99%
“…So far, conclusive evidence has been put forward for the synthesis and secretion of thyrotropin-releasing hormone (5,6), somatostatin (7,8), growth hormone-releasing hormone (8,9), gonadotropin-releasing hormone (10,11), and vasopressin (12,13) by normal anterior pituitary cells. As regards corticotropin-releasing hormone (CRH), 1 mRNA for this hormone has been found in the whole pituitary gland (14) but whether this signal derives from the adenohypophysis or the posterior pituitary, which cells are responsible for CRH gene expression, and whether locally produced CRH in fact modulates corticotrope secretion have not been established.…”
Anterior pituitary hormone secretion is mainly regulated by hypothalamic releasing factors, which reach the pituitary via portal vessels. It has been demonstrated recently that these peptides can also be produced by the pituitary itself, thus possibly modulating hormone secretion in a paracrine/ autocrine fashion. The object of this study was to seek evidence for the synthesis and secretion of corticotropin-releasing hormone (CRH) within the anterior pituitary and to ascertain its biological relevance. Messenger RNA from adult rat anterior pituitary fragments and cell cultures was reverse transcribed and subjected to PCR amplification using primers specific to the rat CRH gene. As in the hypothalamus, a single 232-bp band was obtained. The correspondence of the amplified fragment to the sequence of the
“…Numerous neuropeptides, originally isolated from the hypothalamus based on their hypophysiotrophic activity, have now been located in normal and tumorous anterior pituitary (AP) tissue [1][2][3][4][5][6][7][8][9][10][11][12]. Dependent on the cell of ori gin, gonadal steroids have been implicated in the regula tion of some of these hypophysial neuropeptides [2, 13-lb].…”
The present studies were undertaken to investigate the effect of gender on thyrotropin-releasing hormone (TRH) gene expression in cultured anterior pituitary (AP) cells. AP cells derived from 15-day-old male, female, or female pups that had been neonatally treated with testosterone propionate (TP), were cultured for up to 18 days in a modified DMEM/L-15 medium containing 10% fetal calf serum. TRH and AP hormones including GH, prolactin (PRL), luteinizing hormone (LH) and thyrotropin (TSH) were measured by RIA, proTRH mRNA was determined by in situ hybridization using a full-length riboprobe followed by quantification with a computer-assisted image analysis system. Cultures derived from female rats contained significantly (p < 0.01) higher amounts of TRH and secreted approximately twice (p < 0.01) as much TRH under basal conditions and in response to activators of the protein kinase A and C pathways, respectively. In situ hybridization studies revealed that ‘female’ cultures contained significantly higher amounts of proTRH mRNA compared to ‘male’ cultures. Computer-assisted image analysis demonstrated that proTRH mRNA levels were 3.5 times higher in ‘female’ compared to ‘male’ cultures (p < 0.01), an effect that was the result of a significantly higher number (3 times; p < 0.01) of cells expressing proTRH mRNA in ‘female’ cultures. Neonatal TP treatment did not affect either proTRH mRNA or TRH peptide levels. In vitro testosterone treatment resulted in a moderate rise (p < 0.05) of intracellular TRH accumulation in cultures from both sexes, however, proTRH mRNA levels remained unchanged. Gender-specific differences were also found in the contents of all AP hormones measured: GH and TSH were significantly higher in ‘male’ cultures, while ‘female’ cultures contained larger amounts of LH and PRL. The results show that gender determines the level of TRH gene expression in cultured AP cells. Neonatal androgen exposure does not appear to be a determinant in the sex-specific differences observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.